Rays Power Infra announced closure of INR 127 Crore Equity Capital Fund Raise - RPG Art Foundation unveils ‘Overshoot — Leaning Ecologies’ at Nariman Point, MumbaiHon’ble Shri Rahul Narwekar, Speaker of the Maharashtra Legislative Assembly, inaugurates Arunkumar H G’s new public art installation - Gaja Alternative Asset Management Limited Announced it's Initial Public Offer (IPO) to open on Wednesday, August 19, 2026Price Band has been fixed from ₹ 152 to ₹ 160 per Equity Share - Horizon Industrial Parks Limited Announced its Initial Public Offer (IPO) to open on Monday, August 17, 2026 Price Band has been fixed at ₹ 57 to ₹ 60 per Equity Share - Shankesh Jewellers Limited Announced its Initial Public Offering (IPO) to open on Tuesday, August 18, 2026, Price Band fixed at ₹ 88 to ₹ 93 per equity share of the face value of ₹5 each - MILKY MIST DAIRY FOOD LIMITED ANNOUNCED ITS INITIAL PUBLIC OFFERING (IPO) OF EQUITY SHARES TO OPEN ON TUESDAY 11 AUGUST 2026Price Band fixed at ₹133 to ₹140 per equity share of face value of ₹2 each - Shiprocket Limited Announced it's Initial Public Offer (IPO) to open on Wednesday, August 12, 2026 Price Band has been fixed from ₹ 92 to ₹ 97 per Equity Share - Paramotor Digital Technology expands distribution of Digital Prepaid Payment Solutions with Aditya Birla Capital Digital products - Molbio Diagnostics Limited Announced its Initial public offering (IPO) to open on Monday, August 10, 2026 Price Band fixed at ₹ 768 per equity share of face value ₹1 each to ₹ 807 per equity share of the face value of ₹1 each - US Federal Contractor Tryfacta Achieves Final CMMC Level 2 (C3PAO) Certification, Strengthening Its Commitment to the U.S. Defense Industrial Base - Dhoot Transmission Limited Announced its Initial Public Offering (IPO) to open on Monday, August 10, 2026 Price Band fixed at ₹ 829 per equity share of face value ₹2 each to ₹871 per equity share of the face value of ₹2 each

Pre-term baby from Mauritius with life-threatening heart defect gets new lease of life

The infant was suspected to have Congenital rubella syndrome resulting in Patent Ductus Arteriosus, a heart defect leading to heart failure

Navi Mumbai, 8 August 2022 (GNI): The parents of a four-month-old baby flew 5000 km. from Mauritius to Apollo Hospitals, Navi Mumbai for treatment of a life-threatening heart defect that had left the baby unable to feed and was leading to congestive cardiac failure. The baby was a suspected case of Congenital rubella syndrome that had caused Patent Ductus Arteriosus, a birth defect of the heart. As a result of the defect, the infant’s heart had a volume overload with congestive cardiac failure. Timely diagnosis and intervention by the specialist doctors at Apollo Hospitals, Navi Mumbai, who overcame multiple challenges in closing the heart defect gave the baby a new lease of life.

Dr Bhushan Chavan, Consultant, Paediatrics and Paediatric Cardiology, Apollo Hospitals, Navi Mumbai said, “The case was complicated. The infant had been in the NICU for two long months in Mauritius. He had failed to thrive and his weight at four months of age was the same as at birth, just 2.5 kilos. We were fortunate that he managed the long journey from Mauritius without any major issues. After admission, he was thoroughly evaluated and it was found that the PDA was of significant size for the baby. The standard of care for large PDAs with significant blood flow is closure using either surgical or transcatheter methods. Due to the low weight, it was decided to go in for a minimally invasive interventional closure of the PDA in our advanced Cath-Lab.”

The low weight of the baby and presence of thrombosed veins made the procedure more challenging. Dr Bhushan Chavan said, “While the approach is usually through the femoral vein in the leg, in this case, this was not possible. Due to the baby’s fragile condition, we did not have time and decided to use a new route. We went through the internal jugular vein on the right side of the neck. The margin of error is very low in handling tiny babies and the initial use of a wire through a sheath resulted in slipping and slowing of the heart rate. It was then immediately decided to innovate and use a flexible catheter to guide the wire with the occluding device. We used the smallest device available, a 3×5 mm Lifetech occlude and negotiated it through the guiding catheter and positioned it across the PDA to successfully close and block any flow across it,” stated in the press release.

The position of the device was confirmed through an echocardiogram, a scan used to look at the heart and surrounding blood vessels, which showed complete closure of the heart defect. The two-hour-long procedure was followed by an uneventful recovery with the baby being able to take feeds comfortably. Besides Dr Bhushan Chavan, the clinical team at Apollo Hospitals, Navi Mumbai included Dr Leena Pawar, Anesthetist, and Dr Narjohan Meshram, Paediatric Intensive Care specialist.ends GNI SG

Be the first to comment on "Pre-term baby from Mauritius with life-threatening heart defect gets new lease of life"

Leave a comment

Your email address will not be published.


*